BIBAG

This brand name is authorized in Brazil, Canada, Ecuador, Singapore

Active ingredients

The drug BIBAG contains one active pharmaceutical ingredient (API):

1 Sodium bicarbonate
UNII 8MDF5V39QO - SODIUM BICARBONATE

Sodium bicarbonate has antacid properties. Sodium bicarbonate causes neutralisation of gastric acid with the production of carbon dioxide.

Read about Sodium bicarbonate

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
B05ZA Hemodialytics, concentrates B Blood and blood forming organs → B05 Blood substitutes and perfusion solutions → B05Z Hemodialytics and hemofiltrates
Discover more medicines within B05ZA

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: BR Câmara de Regulação do Mercado de Medicamentos Identifier(s): 509600102152417, 509612040011303, 509612040011403, 509614030014003, 509614030014103
Country: CA Health Products and Food Branch Identifier(s): 02325586, 02487756
Country: EC Agencia Nacional de Regulación, Control y Vigilancia Sanitaria Identifier(s): 28484-05-08
Country: SG Health Sciences Authority Identifier(s): 10583P, 13822P

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.